PHIO
Phio Pharmaceuticals Corp.
$1.20-0.01 (-0.83%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Phio Pharmaceuticals Corp. (PHIO) is a publicly traded company with 6 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 6 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 25 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-05 | Lockshin Curtis | Director | Award | 16,600 | $0.00 | $0 | N/A | N/A |
| 2026-02-06 | 2026-02-05 | Freeman Jonathan E | Director | Award | 16,600 | $0.00 | $0 | N/A | N/A |
| 2026-02-06 | 2026-02-05 | Deming David H | Director | Award | 23,800 | $0.00 | $0 | N/A | N/A |
| 2026-02-06 | 2026-02-05 | Carson Lisa Cabott | CFO | Award | 47,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-06 | 2026-02-05 | Bradford Patricia A | Director | Award | 18,500 | $0.00 | $0 | N/A | N/A |
| 2026-02-06 | 2026-02-05 | Bitterman Robert J | CEO | Award | 120,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-02 | 2025-12-31 | Bitterman Robert J | CEO | Purchase | 5,000 | $1.03 | $5,150 | +17.5% | -1.9% |
| 2025-12-29 | 2025-12-23 | Bitterman Robert J | CEO | Purchase | 5,000 | $1.02 | $5,100 | +0.0% | +5.9% |
| 2025-11-24 | 2025-11-21 | Bitterman Robert J | CEO | Purchase | 5,000 | $1.14 | $5,700 | +10.5% | -3.5% |
| 2025-11-19 | 2025-11-18 | Bitterman Robert J | CEO | Purchase | 5,000 | $1.27 | $6,350 | -5.5% | -16.5% |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.